We are a Mexican trust constituted, primarily, to develop, own, lease, operate, and acquire iconic and premier-quality commercial real estate assets in Mexico. Our objective is to provide attractive risk-adjusted returns to our CBFI holders, over the long-term, through stable cash distributions and the appreciation of our property values. We plan to maintain and grow a high-quality portfolio of properties. This, through our strong and unparalleled development capabilities and selective acquisitions of premier-quality iconic properties. We consider properties to be iconic if they have, the unique ability, to transform the areas surrounding their location. We consider properties to be premier-quality if they are located in prime locations, were developed with high construction and design standards, feature quality tenants, report high occupancy rates and, in the case of retail properties, attract a high volume of visitors and sales per square meter.
| 20.35 | |
| 20.13 | |
| - | |
| 20.79 | |
| 20.13 | |
| 18.5368-21.5 | |
| 31 612 M | |
| 9.3194 | |
| 1 570 M | |
| 6 308 M | |
| 0.0969 | |
| 0.489 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
March 27 (Reuters) - Jounce Therapeutics Inc on Monday agreed to be acquired by privately held Concentra Biosciences for $96.46 million, while spurning a merger deal with British biotech firm Redx Pha...
Shares of Jounce Therapeutics JNCE were up 40.6% on Mar 15 after management announced that Concentra Biosciences (“Concentra”) had made an unsolicited and non-binding proposal to acquire the compa...
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
